Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: ISOLA THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-15 to 2024-09-14
Current total value of award: $455000
Description: PHASE I -TOPIC 431 - DRUG DELIVERY BY ENDOESOPHAGEAL LAVAGE (EEL) TO TREAT ESOPHAGEAL CANCER